top of page
Restoring
the power
of antibiotics
This video was supported by funding from the CSIRO ON Accelerate program and was created by Something™.
Sources: Fleming Initiative (2025). Every 11 Seconds.; GBD 2021 Antimicrobial Resistance Collaborators (2024). Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet.; Brazel, E. B. et al (2022). Dysregulation of Streptococcus pneumoniae zinc homeostasis breaks ampicillin resistance in a pneumonia infection model. Cell Rep.; De Oliveira, D. M. P. et al (2022).
We're on a mission to restore the efficacy of antibiotics against drug-resistant infections
That's why we're developing PBT2.
A small molecule oral therapeutic for treatment of community-acquired bacterial pneumonia (CABP).
PBT2 is orally bioavailable and has shown no development of resistance.
bottom of page